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ABSTRACT 
Apoptosis is a di stinct form of cell death that is characterised by specific morphological 
and biochemical markers, such as chromatin condensation and internucleosomal D A 
cleavage. This type of cell death is evol utionarily conserved in higher eukaryotes. 
Homologues of the main apoptosis regulators, such as the Bcl-2 family of proteins and 
caspases, have been fo und in multicel lular organisms. However, homologues of these 
proteins have not been fo und in the unicellular organism Saccharomyces cerevisiae, 
although in ce1tain circumstances S. cerevisiae wil l exhibit features of apoptosis. In thi s 
project, we developed in vitro systems to explore the relationship between mammalian 
apoptosis and any simi lar mechanism that may be present in yeast. 
Components deri ved from yeast and mammal ian cells were incubated together in vitro and 
assessed for the act ivation of apoptosis. Rat cytochrome c activates apoptosis in 
mammal ian cell-free ext racts (human neuroblastoma SYSY cells). lnternucleosomal DNA 
cleavage was observed in S. cerevisiae spheroplasts when they were incubated in 
mammalian cell-fi·ee extracts a<.:tivated by rat cytochrome c. Although yeast cytochro me c 
is simi lar to rat cy tochrome c, it fa iled to induce apoptosis in mammalian cell-free extracts. 
Y cast cytosol caused internucleosomal D A cleavage in PC 12 nuclei. This cleavage was 
enhanced by rat cytochrome c and was mostly inhibited by the caspase inhibitor 
DEVD-CI-1O, but only in the presence o r rat cy tochrome c. Yeast cytosol did not cause 
chromatin condensation in PC 12 nuclei or cleavage of Parp (a downstream caspase 
substrate). Yeast cytosol was therefore unable to induce apoptosis in PC I 2 nuclei. 
Mitochondria play a central role in most forms of mammalian apoptosis. We developed a 
cell-free system in which we could examine the role of mitochondria in apoptosis. We 
attempted to activate apoptosis in SYSY cytosol by the addition of mitochondria subjected 
to rupture-inducing treatment, with limited success. However, we found that mitochondria 
purified from healthy SYSY cell s protected PC 12 nuclei from undergoing apoptosis in 
vitro . 
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CHAPTER 1: LITERATURE REVIEW 
1.1 WHAT IS APOPTOSIS? 
Apoptosis, or programmed cell death (PCD), is a distinct form of cell death determined by 
a genetically encoded cell suicide program (Kerr et al. , 1972). It allows the rapid, controlled 
and complete removal of unnecessary or damaged cells without di sruption to the 
surrounding cells and thi s process is conserved in all multicellular organisms. Apoptosis is 
characterised by specific morphological and biochemical changes that require the cell to be 
metabolically act ive and depends on RNA and protei n synthesis in most, but not all , cell 
types (Wyllie el al. , 1984). During apoptosis, DNA is cleaved first into large 50 kB loops 
and then cleaved internucleosomally (Wyllie et al. , 1980b), while concurrently chromatin 
condenses (Kerr el al. , 1972). Finally, the membrane starts to bleb (bud) and the cell 
breaks into small apoptotic bodies, which are rapid ly engulfed by nearby cells (F igure 1-1 ) 
(E lli s el al. , 1991a; Elli s el al. , 199 1b). Assays for these changes can be used as a basis for 
determining whether a cell is undergoing apoptosis or necrosis. 
In contrast, cell death by necrosis, is largely uncontro lled and results in the release of 
ox idative enzymes and free rad icals that inflame the surrounding healthy ti ssue. Necrotic 
cell death is characterised by the earl y dilation of cytoplasmic organelles, fo llowed by the 
rupture of cell membranes causing an inflammatory response (Figme 1-1 ) (Wy llie el al., 
1980a). Necrotic DNA degradation is a late phenomenon , detected several ho urs after 
cellular degeneration is observed. It is thought that chromatin digestion by the cell ' s 
nucleases and proteases is a consequence rather than the cause of cell death (Duvall and 
Wyllie, 1986). 
1-1 
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organel !es including 
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breaks into apoptotic bodies that 
are phagocytosed by surrounding 
cells. 
Figure 1-1: Comparison of apoptotic and necrotic cell death. 
Initial features of apoptotic cell death are the shrinkage of the cell and internal organelles, 
fo llowed by the cleavage of the genomic DNA and break up of the cell into apoptotic 
bodies, which are engulfed by the surrounding cells. In contrast, during necrotic cell death 
the cell swell s and internal organelles burst, spilling the cells' contents into the surrounding 
tissue. 
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1.2 APOPTOSIS AND ITS CONTROL 
Apoptosis plays many important roles in shaping the final form of an organism during 
development, for example, the removal of inter-digital cells to shape fingers. Multicellular 
organisms also use apoptosis as a defence mechanism. For example, cells will cornmit 
suicide when exposed to viruses, which eventually leads to the shutdown of D A and 
RNA synthesis so new viruses cannot be made. The D A endonucleases activated during 
PCD will cleave both the host and viral D A eliminating the virus completely and 
therefore protecting the whole organism (Vaux et al., 1994). 
Apoptosis plays a prominent role in the development of the mammalian nervous system 
(Oppenheim, 1991 ), and it is vital that strict control is maintained over its initiation. When 
mammalian neurons are formed they attempt to make connections with other neurons, and 
those that do not make the correct connections undergo apoptosis. As many as 85% of 
certain populations of developing neurons will undergo PCD (Ellis et al. , 1991 b). The 
failure of neurons to undergo apoptosis during development may cause the formation of 
tumours. 
Understanding the molecular mechanisms of apoptosis and identifying its mechanism of 
activation will provide benefits for hwnan health. Abnormal control of apoptosis may 
play a role in neurodegenerative disorders such as Parkinson 's disease and A lzheimer' s 
disease. In fact , in Alzheimer diseased brains, leve ls of pro-apoptotic proteins such as Bad 
(Bcl-XL/Bcl-2 associated death promoter) and Bak were elevated when compared with 
normal brains (Kitamura et al., 1998). 
1.3 THE NEMATODE MODEL FOR APOPTOSIS 
The nematode Caenorhabditis elegans has been extensively studied and provides a genetic 
model for PCD (Hengartner and Horvitz, 1994c ). C. elegans requires the birth of 1090 
somatic cells to produce an adult nematode, but 131 of these cells die during development. 
The specific 131 cells that die are always the same in all developing nematodes (Ellis et al., 
1-3 
1991 b ), and their fate is predetermined. The removal or death of surrounding cells does not 
affect the timing or manner of the death of these 131 cells, indicating that the death process 
is cell autonomous (Hedgecock et al., 1983). Three genes, ced-3, ced-4 and ced-9 (cell 
death abnormal) were identified in which mutations affected these programmed cell deaths 
(Ellis and Horvitz, 1986; Hengartner et al., 1992). Blocking apoptosis in nematodes is not 
lethal, and produces an organism with only a few minor functional problems making them 
an ideal organism to study (Ell is et al., 1991 b; Jacobson et al., 1997). 
The central cell death machinery involving the ced-3, ced-4 and ced-9 genes has been well 
characterised . Proteins encoded by ced-3 and ced-4 (Ced-3 and Ced-4, respectively) cause 
cells to undergo programmed cell death , while the Ced-9 protein antagonises their actions 
and protects cells from death (Horvitz et al. , 1994). Overexpression of either the ced-3 or 
ced--1 genes induces apoptosis, but a functional Ced-3 protein is required for Ced-4 induced 
death (Shaham and Horvitz, 1996). Ced-3, ced-4 and ced-9 are constitutively expressed, 
suggesting that expression of all three genes is required not only for PCD but also for 
survi va l of the cell (Shaham and Horvitz, 1996). 
The mechanism by which these proteins act to induce or prevent apoptosis has been 
established through both genetic and biochemical analysis and is diagrammatically 
rep resented in Figure 1-2. Ced-9, a mitochondria membrane-associated protein , no1mally 
sequesters Ced-4 (Chen et al. , 2000; Wu et al. , 1997). Fo ll owing an apoptotic signal, Ced-9 
releases Ced-4 into the cytosol , where it can bind and activate the ~ysteine aspartic acid 
.12.rotease (caspase), Ced-3 (Wu et al., 1997). Ced-4 binds Ced-3 through a caspase 
recruitment .domain (CARD domain) found on both proteins, an interaction that requires 
ATP and results in a conformational change in Ced-3 (Zou et al. , 1997). Caspases are 
present in the cell in an inactive precursor form, which is activated by the cleavage of the 
pro-domain and the formation of a heterotetramer of the two domains of the protein. 
Following processing and activation, Ced-3 cleaves proteins at aspartate residues at a 
specific sequence, DEVD (Yuan et al. , 1993). 
1-4 
Death stimulus 
8 
Pro-Ced-3 
Cleavage 
... 
APOPTOSIS 
Figure 1-2: Diagrammatic representation of the interaction of the Ced proteins and 
Egl-1. 
Ced-4 is normally sequestered by Ced-9 at the mitochondria membrane in live cells. Egl-1 
is produced in response to upstream signals and initiates cell death by displacing Ced-4, 
which then binds Ced-3 causing it to autoactivate and carry out the execution of the cell. 
This figure is adapted from Metztein, et al. , (1998) and de Peso, et al., (1998) . 
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A fourth gene in the nematode apoptosis model, egl-1 (egl, ~ Jaying defective gene), was 
rece ntly cloned. Egl-1 encodes a protein that disrupts the interaction of Ced-9 with Ced-4 
(Conradt and Horvitz, 1998; de! Peso el al., 1998). The currently accepted model of the 
interaction between these fo ur proteins Egl-1 , Ced-3 , Ced-4 and Ced-9 has been depicted in 
Figure 1-2. Egl-1 is produced in response to a death signal and initi ates apoptosis b y 
binding d irectly to Ccd-9, displacing Ced-4 (Conradt and Horvitz, 1998; de! Peso el al., 
199 8), which can then bind Ced-3 and mediate the initiati on of cell death . 
Some programmed cell death events in the nematode, including those in the sister cells of 
the serotorunerg ic neurosecretory motor (NS M) neurons, are controlled by the expression 
of ces-1 and ces-2 (ce ll death 1:i pecifi cation genes) (E lli s and Horvitz, 199 1 ). Ces-2 encodes 
a transcripti on factor, which regul ates the ex pression of egl-1 in the pharynx (Metzste in el 
al., 1996; Metzs tein el al. , 1998), and also ac ts as a negative regula tor of ces-1. Egl-1 ,. 
expression is a lso repressed by Tra-1 A, a protein involved in sex-determination of the 
nematode, which di ctates whether the hermaphrodite sister neurons (HSN) die (Conradt 
and Horvitz, 1999). 
Geneti c ana lys is has identi fied a set of genes encoding pro teins that ac t downstream of 
Ced-3. These pro te ins (Ced-I , Ced-2, Ced-5 , Ced-6, Ced-7, Ced- IO, and N uc-1 ), are 
invo lved in the phagocy tos is and degradat ion of the cell corpses (Elli s el al. , 199 1a; 
Hevelone and Hartman, 1988 ; Sul ston, 1976) . 
The regulati on of apoptos is in C. elegans has provided a framework w ith w hi ch to ide ntify 
the components involved in the programmed cell death mechanism. The limitation of the 
C. elegans model is the tinting of these apoptotic cell deaths is only during the 
development of the nematode. 
1.4 MAMMALIAN MODELS OF APOPTOSIS 
The mammalian apoptotic process is more complex than the nematode model. Two 
me thods of programmed cell death in mammals have been identified, cytochrome c 
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( cyt. c )-mediated and death receptor-mediated cell death. In the former case, cells receive 
survival signals that tell them to tum off the PCD mechanism. Mammalian cell survival is 
thus an active process, which requires signalling pathways to be constantly activated. 
Extracellular growth facto rs, for example NGF (nerve growth factor) in neurons, operate to 
turn o n cell surv ival signalling pathways. In cases where the cell fails to bind/recognise 
these factors, PCD (cyt. c-mediated apoptosis) is activated, which invo lves the release of 
apoptogenic prote ins from mitochondria (Raff, 1992). In death receptor-mediated 
apoptosis, li gands such as Fas li gand (a cytokine from the Tumour Necrosis Factor family) , 
bind to their respecti ve cell receptors, and act ivate PCD directl y. 
1.4.1 Mammalian cell death decisions involve Apaf-1, 2, 3 and 
Bcl-2 
The central playe rs in mammalian apoptosis have been identified as mammalian 
homologues of ced-3, ced--1 and ced-9. Bcl-2, a proto-oncogene, was found to encode the 
functio nal homologue of ced-9 (Hengartner and Horvitz, 1994b), and has been shown to 
de lay or prevent programmed cell death of many kinds of cells exposed to a vari ety of 
stimuli . In fact , Bcl-2 and Ced-9 proteins are able to substitute for each other in nematodes 
and mammalian cells (Hengartner and Horvitz, 1994b). Bcl-2, like Ced-9, is fo und 
associated with the mitochondrial membrane (Hackenbery et al. , 1990), however thi s 
membrane attachment is not necessary for the cell surv iva l act ivity of thi s protein (Borner 
et al. , 1994). Bcl-2 prevents both the release of cy t. c (a pro-apoptotic protein in 
mammals) from mitochondria and act ivati on of caspases by cyt. c-activated Apaf- 1 
(A poptosis promoting factor 1) (Kluck et al. , 1997a; Rosse et al., 1998). 
Apaf-1 was purified from cytosolic cell extracts used in an in vitro system designed to 
mimic apoptosis in the test tube. This protein is encoded by the mammalian homologue of 
ced-4 (Zou et al., 1997). Three other factors that are required to induce apoptosis, cyt. c 
(a lso known as Apaf-2), ATP, and Apaf-3, were also identified in the same manner (Li et 
al. , 1997b; Liu et al., 1996). Apaf-3, the third apoptosis-activating factor, is a caspase and 
is identical to, and now called, Caspase-9 (Alnemri, 1997; Li et al., 1997b ). Apaf-1 binds 
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to cyt. c , and concomitantly binds and hydrolyses ATP to ADP in a reaction that appears 
to promote Apaf-1 oligomerisation (Figure 1-3) (Zou et al., 1999). The multin1eric 
complex containing Apaf-1 and cyt. c is termed an apoptosome, which recruits and 
activates Caspase-9 (F igure 1-3) (Li el al., 1997b; Zou el al., 1999). Active Caspase-9 
activates Caspase-3 by cleaving off the pro-doma in of the protein , initiating a caspase 
cascade (Li el al., 1 997b; Zou et al. , 1997). 
1.4.2 Execution and degradation of the cell 
O nce the caspases are acti ve, the death of the cell is irreversible. The initiator caspases -
Caspase-9 , in the cy t. c-mediated caspase cascade, and Caspase-8 , in death 
receptor-acti vated apoptos is, acti vates effector caspases, such as Caspase-3 and 
Caspase-7. The effector caspases have the job of activating all the downstream prote ins 
invo lved in the destructi on and packagi ng of the cell into small apoptoti c bodies ready fo r 
phagocy tos is by the neighbouring ce ll s. 
So fa r twelve caspases have been identified , including the initiator caspases -8 and -9. 
Some of these caspases have been placed in to subgroups according to the ir substra te 
preference. Gro up l (Caspase-1 , -4, and -5) prefer the tetrapeptide sequence WEHD . 
Gro up II (Caspase-3, -7, -2) have a preference fo r the DEXD sequence, and Group III 
(Caspase-6, -8 , -9) will cleave proteins at a (IN /L)EXD consensus sequence (Rano el al., 
1997; Thornberry el al., 1997). Group III caspases can cleave group II caspases, caspases 
within their own group, and other proteins such as poly-(ADP)-ribose polymerase (Parp), 
a D A repair enzyme. 
1-8 
dATP/ATP Pi 
~ dADP/AD1/ 
Apaf-1 ~~·67 Apoptotic stimuli i 
--- 0 cytochrome c 
mitochondria 
°tJ 
active caspasc-9 
pro-caspase-3 
Dl--~-
Figure 1-3: Schematic model of the activation of Caspase-9. 
Apaf--1--mediated hydrolysis of ATP causes a conformational change in Apaf-1. Cyt. c 
binds this form of Apaf-1 and promotes oligomerisation into a multimeric complex, which 
recruits and activates Caspase-9. Active Caspase-9 promotes downstream processing of 
other caspases. This figure is adapted from Zou, et al., (1999). 
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Most of the caspases have specific downstream targets in vivo, and perhaps the Caspase-3 
targets are understood the best. Parp cleavage by Caspase-3 and Caspase-7 is a hallmark 
for apoptosis (Casciola-Rosen et al. , 1996; Salvesen and Dixit, 1997). Gelsolin, thought to 
sever actin filaments, is activated by Caspase-3 cleavage, and the active form is involved in 
cell blebbing (Kothakota et al. , 1997). Caspase-3-activated Acinus, a recently identified 
apoptotic factor , is required for chromatin condensation (Sahara et al. , 1999). Caspase-3 
disables several other DNA repair machines and mRNA splicing machinery (Casciola-
Rosen et al. , 1996; Casciola-Rosen et al. , 1995; Casciola-Rosen et al., 1994). It also cleaves 
stero l producing proteins and activates cyclin dependent kinases (cdk) by cleavage of cdk 
inhibitors (Goldberg et al. , 1996; Kaufmann et al., 1993 ; Levkau et al. , 1998; Wang et al. , 
1 995 ; Waterhouse et al. , 1996; Zhou et al. , 1998). 
The caspases are also involved in the cleavage of cell survival signalling molecules during 
apoptosis , such as Ras GTPase-activating protein Raf-I , and Akt-1 , which turns off cell 
survival (Francois and Grimes, 1999; Widmann et al. , 1998). 
1.4.3 DNA fragmentation 
Caspase-activated deoxyribonuclease (Cad) and its inhibitor (lead) have both been isolated 
and characterised from a mouse cell line (Enari et al. , 1998; Sakahira et al. , 1998). During 
apoptosis, lead is cleaved by Caspase-3, releasing Cad and allowing it to translocate to the 
nucleus (Sakahira et al. , 1998). The COOH terminus of Cad has a sequence of 15 amino 
acid residues which has the features of a nuclear localisation signal (Dingwall and Laskey, 
1991). This sequence is masked by lead and is revealed when the inhibitor is cleaved. 
Removal of lead activates and allows nuclear targeting of Cad. lead is expressed in two 
alternate forms called lead-sand lead-I, the long form is mostly found complexed with Cad 
and works as a specific chaperone for CAD facilitating its correct folding during synthesis 
(Sakahira et al., 1999). 
1.4.4 Bcl-2 family of proteins 
Following the identification of Bcl-2, similar proteins were discovered with regions of high 
homology, termed Bcl-2 homology (BH) domains. These proteins are now known to be 
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part of a growing family of proteins called the Bcl-2 family of proteins. The members of 
the Bcl-2 family of proteins are either anti -apoptotic i.e. Bcl-2 and Bel-XL, or pro-
apoptotic i.e. Bax, Bad, and Bid, and are generally found associated with intercellular 
membranes (Adams and Cory, 1998). Certain members of the family, such as Bax or Bad, 
remain in the cytosol where they await a death signal that causes their translocation to the 
outer mitochondrial membrane (Adams and Cory, 1998; Li et al., 1998; Luo et al., 1998; 
Puthalakath et al., 1999; Wolter et al. , I 997). Most of the Bcl-2 proteins contain a 
carboxyl terminal transmembrane tail , which targets these proteins to intracellular 
membranes (see Figure 1-4) (Nguyen et al., 1993). In most instances, localisation of the 
Bcl-2 fami ly of proteins to the mitochondria is important for the promotion or inhibition of 
cell death . For example, the translocation of the pro-apoptotic protein Bax from the 
cytosol to the mitochondria is necessary for Bax to induce cell death (Gross et al., 1998; 
Hsu et al. , 1997; Nguyen et al. , 1994; Putcha et al. , 1999; Wolter et al., 1997). 
The Bcl-2 family of proteins share structura l and functional similarity with Ced-9 (Adams 
and Cory, 1998; Hengartner and Horvitz, I 994a; Hengaitner and Horvitz, 1994b ). 
Sequence alignment of these proteins has identified four main regions of homology, which 
have been designated Bcl-2 homology (BH) domains - BH 1, BH2, BH3 and BH4 (Figure 
1-4) (Chittenden et al., 1995 ; Yin et al. , I 994; Zha et al., I 996a). The BH3 domain is 
sufficient for the pro-apoptotic proteins of this family to act as death st imuli , and for some 
proteins, such as Bad, this is the only region of homology with the rest of the family 
(Ottilie et al., 1997). The BHl and BH2 domains are crucial for the anti-apoptotic 
properties of Bcl-2 enabling it to suppress cell death by heterodimerising with Bax (Yin et 
al. , 1994). 
1- 11 
Pro-survival 
BH4 BH3 BHl BH2 TM 
Bcl-2 
Bel-XL 
Mcl-1 
Pro-apoptotic 
Bax 
I r)! I I 11 Bak 
Bad 
Bid 
Egl-1 
Figure 1-4: Schematic representation of the Bcl-2 family members and Egl-1. 
The Bcl-2 homology (BH) domains and hydrophobic membrane-targeting domain (TM) are 
indicated. The deletion in Bcl-Xs resulting from differential splicing is indicated by dashed 
lines. The proteins are not drawn to scale. This figure is adapted from Rao and White, 
(1997) and Adams and Cory, (1998). 
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1.4.5 Phosphory lation of Bad promotes cell survival 
Bcl-Xs and Bad are involved in the indirect promotion of mammalian cell death by 
sequestering anti-apoptotic proteins like Bcl-2 (Boise et al., 1993; Yang et al., 1995). Bad 
is phosphorylated in the presence of several cell survival factors such as interleukin-3 
(IL-3) or through the activation of a cell survival pathway such as the phosphatidyl 
inositol -3 kinase (PI-3 kinase) pathway. Phosphorylated Bad is unable to dimerise with 
Bcl-2 and therefore promotes cell survival shown in Figme 1-5 (Datta et al., 1997; Zha el 
al., 1996b). Akt, also called protein kinase B (PKB), is activated by the PI -3-kinase 
pathway and is capable of phosphorylat ing Bad, as shown in Figure 1-5 (Dudek et al. , 
1997; Kauffmann-Zeh el al., 1997). Mitochondrial-anchored Protein Kinase A, which is 
activated in the presence of the survival factor IL-3 , is also known to phosphorylate Bad 
(Harada et al., 1999). Phosphorylated Bad is sequestered in the cytosol by 14-3-3, which 
binds phospho-serine residues in proteins, inhibiting mitochondria localisation (Figme 1-5) 
(Zha el al., 1996b). 
In the absence of cell survival signals such as, phospho-Akt, Bad is not phosphorylated 
and is able to heterod imerise w ith Bcl-2 and Bel-XL (Otti lie et al., 1997). This interaction 
prevents the cell survival activities of Bcl-2 by displacing pro-apoptotic proteins, like Bax 
(Figure 1-5). Displaced Bax is then able to translocate to the mitochondria and induce cyt. 
c release. 
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Figure 1-5: Phosphorylation of Bad prevents mitochondria-mediated apoptosis. 
In the presence of cell survival signals, such as phospho-Akt, Bad is phosphorylated, and 
then sequestered in the cytosol by 14-3-3 . In the absence of these survival signals, Bad is 
not phosphorylated, and heterodimerises with Bcl-2, displacing pro-apoptotic proteins, 
like Bax, which can then translocate to the mitochondrial membrane causing the release of 
cyt. C. 
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1.5 MITOCHONDRIA-MEDIA TED APOPTOSIS 
Interactions of proteins on the mitochondrial surface dictate the cells' fate in most 
instances of programmed cell death. Indeed, when cell-free systems were developed it was 
discovered that extracts enriched in mitochondria were required for the induction of 
apoptosis (Newmeyer et al. , 1994). While mitochondria produce metabolic energy for the 
cell in the form of ATP, they also harbour proteins that are lethal to the cell such as cyt. c 
and apoptosis inducing factor (AIF) (Susin et al., 1999). Cyt. c is an essential protein in 
the electron transport chain and is also required for the induction of in vitro reconstitution 
of apoptosis. Cyt. c has been described as a double-edged sword, because without it the 
cell would halt metabolic activity , yet if released into the cytoplasm it can initiate 
apoptosis in conjunction with Apaf- 1. 
Cyt. c is released through the outer mitochondrial membrane during apoptosis (Newmeyer 
and Green, 1998; Reed, 1997). Along with ATP or dA TP, cyt. c is required for the 
induction of apoptosis in cell-free systems (Francois and Grimes, 1999; Liu et al., 1996). 
Microinjection of mammalian cyt. c into human kidney 293 cells, mouse embryonic Swiss 
3T3 fibroblasts , normal rat kidney (NRK) epithelial cells, or rat promyelocytic IPC-81 
leukaemia cells induces apoptosis, which is inhibited by overexpression of Bel-XL or Bcl-2 
(Li et al., 1997a; Zhivotovsky et al., 1998). Interestingly, microinjection of higher 
concentrations of cyt. c was required to induce apoptosis in whole cells, compared with the 
amount required in cell-free systems, which indicates the involvement of other survival 
factors within the cell (Li et al., 1997a; Zhivotovsky et al., 1998). Indeed, neurons 
maintained with NGF and microinjected with cyt. c did not undergo apoptosis indicating 
that another event was required before the complete induction of apoptosis (Deshmukh 
and Johnson, 1998). 
During apoptosis in vivo, cyt. c is redistributed from mitochondria to the cytoplasm 
(Goldstein et al., 2000; Martinou et al., 2000; Neame et al. , 1998). A major unresolved 
question is, how is cyt. c released? Alteration of the mitochondrial structure, its function, 
and membrane depolarisation, have been reported during apoptosis (Mancini et al. , 1997; 
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Petit et al., 1995). Members of the Bel-2 family have been implicated in the changes 
reported in mitochondria during apoptosis. In whole cells, overexpression of Bax induces 
the early release of cyt. c, which is inhibited by the expression of Bel-XL (Finucane et al., 
1999). Small amounts of recombinant Bax can induce the release of cyt. c from isolated 
mitochondria, which is prevented by the addition of recombinant Bel-XL (Jurgensmeier et 
al., 1998). The pro-apoptotic Bcl-2 family members, Bid and Bax, caused the release of 
cyt. c from isolated mitochondria, but required the presence of a macromolecular cytosolic 
factor called permeability enhancing factor (PEF) to complete the permeabilisation of the 
mitochondrial outer membrane (Kluck et al., 1997a; Kluck et al., 1999). 
Two models have been proposed to explain how factors such as cyt. c is released from the 
mitochondria. The first model requires a permeability transition resulting in the swelling 
and subsequent rupture of mitochondrial membranes, while the second model proposes the 
opening of a specific pore al lowing the release of apoptogenic factors without disruption of 
the mitochondrial membranes (F igure 1-6) (Green and Reed , 1998; Martinou, 1999). These 
models are presented below. 
1.5.1 Cyt. c release from mitochondria - Model I 
When a permeability transition is induced in isolated mitochondria, they swell and release 
apoptogenic proteins (Scarlett and Murphy, 1997). A megachannel called the permeability 
transition pore (PTP) is thought to open during apoptosis allowing H2O and other solutes 
to enter mitochondria and the release of proteins such as cyt. c. The PTP is made up of 
several proteins including the adenine nucleotide translocator (Ant) and porin (voltage 
dependent anion channel; Vdac), located on the inner and outer mitochondrial membranes, 
respectively , which act in concert to create the PTP (Figure 1-6) (Green and Reed, 1998). 
Vdac/Antalso act to allow ATP/ADP exchange, and an early event in apoptosis has been 
found to be a defect in mitochondrial ATP/ ADP exchange (Vander Heiden et al., 1999). 
Ant and Bax were found to interact directly with one another, and ectopic expression of 
Bax induced cell death in wild type yeast but not Ant-deficient yeast, indicating that the 
interaction of these two proteins is important for apoptosis (Marzo et al., 1998). 
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1.5.2 Cyt. c release from mitochondria - Model II 
Model II suggests that cyt. c is released without rupture or swelling of the mitochondria. 
Indeed, cyt. c is released by Bax in the presence of PTP inhibitors without any detectable 
swelling of mitochondria (Eskes et al., 1998; Jurgensmeier et al., 1998; Kluck et al., 1999). 
Pro- and anti-apoptotic members of the Bcl-2 family have been shown to bind Vdac and 
regulate the release of cyt. c. (Shimizu et ed., 1999). Interestingly, the diameter of V dac is 
too small to allow cyt. c to pass through, so it is possible that Bax and Bak interact with 
V dac to form a multi protein channel that allows the passage of cyt. c (Figure 1-6). 
In addition to these two models for cyt. c release from mitochondria, other models of cyt. c 
release have been proposed (Martinou et al., 2000). The validity of any of these models 
may depend on cell type or apoptotic stimulus. In some cell types, ce11ain stimuli initiate 
death receptor-mediated cell death, rather than using the default mitochondrial-mediated cell 
death pathway, which is turned on in the absence of cell survival signals. Death receptor-
mediated cell death is outlined in the next section. 
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Figure 1-6: Models for the release of cyt. c from mitochondria. 
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Model I - Bax interacts with both Ant and Vdac to form a permeability transition pore 
(PTP), which allows water and solutes to enter the mitochondrion causing the matrix to 
swell and its outer membrane to rupture. The result is the release of cyt. c and other 
proteins. Model II - The conformation of V dac changes after interaction with Bax or Bak. 
V dac fo1ms a larger channel , possibly in combination with Bax that is permeable to cyt. c, 
but the integrity of the outer mitochondrial membrane is maintained. 
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1.6 DEA TH RECEPTOR-MEDIA TED APOPTOSIS 
An apoptotic cell death pathway that is switched on from an external source involves 
'death factors' one of which is the Fas ligand (Fas L). This type of cell death is termed 
death receptor-mediated cell death. The Fas L is a cytokine, belonging to the tumour 
necrosis factor (TNF) family (Suda et al., 1993), and its receptor, Fas/CD95, belongs to the 
T F receptor family (ltoh et al. , 1991; Oehm et al. , 1992). Binding of Fas L to Fas 
induces trimerisation of the receptor and it is the trimerised cytoplasmic region of Fas, 
known as the death domain, that transduces the death signal (Figure 1-7) (Banner et al. , 
1993; Itoh and Nagata, 1993; Tartaglia et al., 1993). Fas-mediated apoptosis causes cell 
death within hours of the ligand binding its receptor. It does not require any protein 
synthesis, which suggests that the components required for death receptor-mediated 
apoptosis are already present and Fas activation simply triggers the mechanism (Itoh et al., 
1991; Yonehara et al., 1989). Tumour cells, such as melanoma, have an elevated level of 
expression of the Fas ligand, which induces apoptosis in the Fas-bearing cytotoxic T 
lymphocytes (Hahne et al., 1996). This subversion of the Fas-mediated cell death 
pathway is an effective survival tactic by the tumour cells . 
To identify the molecules that bind to the cytoplasmic region of Fas, several groups made 
use of the yeast two-hybrid system. A molecule called Fadd/Mortl (Fas-associating 
protein with death domain) was identified and shown to bind trimerised Fas through a 
death domain depicted in Figure 1-7 (Boldin et al. , 1995; Chinnaiyan et al. , 1995; Kischkel 
et al. , 1995). 
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Figure 1-7: Death receptor-mediated apoptosis. 
Fas receptor molecules trimerise following ligand binding, which allows the recruitment of 
Fadd, then Caspase-8, which is subsequently activated. Active Caspase-8 triggers a 
caspase cascade and cleaves Bid. The COOH-terminal part of Bid (tBid) translocates to 
the mitochondria and triggers the release of cyt. c possibly by a mechanism analogous to 
that shown in Figure 1-5. This figure is adapted from Gross et al. (1999). 
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Fadd/Mortl also contains a CARD domain, which recruits Caspase-8 (previously called 
Mach or Flice ), the next factor in the Fas apoptotic pathway (Alnemri et al., 1996; Boldin 
et al. , 1996; Muzio et al., 1996). This interaction is sufficient to induce the autoactivation 
of Caspase-8 in a manner similar to that of Caspase-9. Active Caspase-8 then cleaves 
Caspase-3, starting a caspase cascade and irreversible cell death (Figme 1-7) (Boldin et al. , 
1996). Caspase-8 also cleaves Bid releasing the COOH-terminal part of the protein (tBid) , 
which translocates to mitochondria niggering cyt. c release in a type of feedback 
amplification loop (Figure 1-7) (Gross et al. , 1999; Li et al. , 1998; Luo et al. , 1998). 
There are other death receptors that function in a similar manner to Fas, these all belong to 
the TNF (tumour necrosis factor) receptor super family. Members of this family include 
TNFRl , Fas, death receptor (DR) 3, DR4, DRS, DR6 and p75 Nrn, all of these receptors ,, 
contain homologous cytoplasmic death domains. In each case, binding of the receptors • 
respective ligands, causes oligomerisation of the receptor, which can bind adapter proteins 
containing death effector domains (OED) and initiate the activation of Caspase-8 
(Ashkenazi and Dixit, 1998). 
1.7 DROSOPHILA MELANOGASTER MODEL OF 
APOPTOSIS 
Drosophila melanogaster has recently been identified as a model organism for the study of 
apoptosis. Since a large numbers of cells undergo apoptosis during both embryonic • 
development and metamorphosis of Drosophila (Steller and Grether, 1994; Truman et al. , 
1992), and the organism can be readily manipulated for both genetic and biochemical 
analysis, it is an ideal model organism in which to explore apoptosis 
1.7.1 Initiation of apoptosis in Drosophila 
Deletions in the H99 locus block apoptosis in Drosophila. This region of the Drosophila 
genome contains three activators of apoptosis, reaper (rpr) , hid (head involution defective) 
and grim (Chen et al. , 1996; Grether et al. , 1995; White et al., 1994). Ectopic expression of 
rpr, hid or grim induces apoptosis, and the transcriptional activation of these genes 1s 
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necessary for apoptotic cell death. Cell death in Drosophila is blocked by caspase 
inhibitors, indicating that the H99 genes induce death via a caspase-mediated pathway 
(Chen et al., 1996; Grether et al., 1995; White et al., 1994). 
As with mammalian cells, it appears that the PI-3 kinase pathway plays a role in apoptosis 
in Drosophila. The Drosophila Akt homologue, Daktl is required to prevent apoptosis 
(Franke et al., 1994; Staveley et al., 1998). Apoptosis caused by loss of Daktl function 
was prevented by suppression of the caspases through ectopically expressing p35 (a 
baculoviral caspase-inhibitory protein) (Staveley et al., 1998). Epistatic analysis of the 
Dakti gene with the grim, rpr and hid genes shows that Daktl acts downstream and may 
be repressed by the H99 locus (Stave ley et al. , 1998). 
1.7.2 Drosophila Apoptosome 
From the emerging Drosophila model it appears that cyt. c is required for Drosophila 
apoptosis. However, any link between the grim, hid and reaper genes and release of cyt. c 
from mitochondria has not been fully established. Using in vitro studies Rpr was shown to 
bind a Xenopus protein called Scythe, causing the release of another protein that induces 
cyt. c release in purified mitochondria (Thress et al., 1999; Thress el al., 1998). While 
homologues of these two proteins have not been described in Drosophila, homologues of 
proteins in the mammalian apoptosome and downstream targets have been found. 
The Apafi and caspase-9 Drosophila homologues were cloned and called dark and dredd 
respectively (Chen et al., 1998; Kanuka et al., 1999; Rodriguez et al., 1999; Zhou el al., 
1999). Apoptosis induced by the ectopic expression of grim, hid and rpr is reduced in 
dark mutants indicating that Dark acts downstream of these three genes (Figure 1-8) 
(Rodriguez et al., 1999). The Dark protein contains a CARD domain and the san1e WO 
repeat region that binds cyt. c in Apaf-1, and deletion of this WO repeat region results in a 
more apoptotically active molecule as a level of control is lost (Hu et al., 1998; Rodriguez 
et al., 1999; Srinivasula et al. , 1998). 
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Figure 1-8: Model of apoptosis in Drosophila. 
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Grim, Rpr and Hid are believed to promote apoptosis by disrupting interactions between 
laps and Caspases. Rpr, Hid and Grim may cause cyt. c release through an unknown 
factor. Released cyt. c binds Dark, which can then activate the activator caspases, Drone 
and Dredd. The activator caspases can then activate effector caspases, Drice and Dcp-1 . It 
is proposed that Grim, Rpr, and Hid also bind Diap 1, removing its inhibitory effect on the 
effector caspases, Drice and Dcp-1. Rpr, Hid and Grim have also been proposed to 
activate Dark directly. Known mammalian homologues are indicated in brackets. 
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Conformational changes were observed in cyt. c in Drosophila nurse cells that are known 
to undergo apoptosis. Cyt. c displayed an otherwise hidden epitope that is highly specific 
for these pre-apoptotic cells, this conformation change did not occur in cells destined to 
survive (Thress et al., 1999; Varkey et al. , 1999). As more data comes to light the 
regulation of the release and changes in cyt. c will become clear. 
While man1111alian Caspase-9 requires its CARD domain for its interaction and activation 
by Apaf-1 , it is unclear whether Drosophila caspases require a CARD domain for their 
activation. The interaction of Dredd with Dark does not appear to be mediated by CARD 
domains, which these proteins lack. Interestingly, another recently identified caspase 
Drone does contain a CARD domain (Dorstyn et al. , 1999a). To date, three more caspase 
genes have been identifi ed: Decay, Dcpl and Drice, and the proteins encoded by these 
genes seem to resemble effector-type or executioner caspases (Dorstyn et al. , 1999b; Fraser 
and Evan, 1997; Song et al. , 1997). 
Another family of proteins fo und in most multicellular organ isms and some wlicellular 
organisms are called inhibitors of apoptosis (laps) , and these proteins appear to bind and 
inhibit caspases (Uren et al. , 1998). The effector caspases, Drice and Dcp-1 , which are 
normally sequestered by Drosophila inhibitors of apoptosis (Diap) are released by the 
action of Hid on Diap 1 (Figure 1-8) (Wang et al., 1999). 
1.8 APOPTOSIS IN UNICELLULAR ORGANISMS 
While the apoptotic mechanism has been characterised in multicellular organisms, no similar 
mechanism for apoptosis has been found in tmicellular organisms. The genomes of several 
unicellular organisms have been fully sequenced i.e. Escherichia coli , Saccharomyces 
cerevisiae (Blattner et al. , 1997; Goffeau et al., 1996) and no homologues of the apoptotic 
genes mentioned above have been found. However, in certain circwnstances these 
unicellular organisms do show features characteristic of apoptosis. 
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1.8.1 Cell death in Bacteria 
Expression of mammalian pro-apoptotic proteins in E. coli is lethal. E. coli expressing Bax 
were unusually elongated, and showed a 6-fold increase in monounsaturated fatty acids, 
along with an increased consumption of oxygen (Asoh et al., 1998). The increase in oxygen 
consumption is correlated w ith an increase in the production of ' reactive oxygen species' 
(ROS), which consequently increases the frequency of DNA mutati ons bringing about cell 
death (Asoh et al., 1998). It is not yet clear how these observations re late to the apoptotic 
mechanism. 
1.8.2 Cell death in Unicellular Eukaryotes 
Yeast, such as Saccharomyces, cerevisiae are simple unicellular eukaryotic organi sms. At 
present there is a great deal of debate as to whether yeast actually undergo apoptosis. 
When yeast are made to express recombinant death inducing proteins , such as Bax, very 
low yie lds of these proteins are recovered , due to the fact that the yeast die . A lethal 
phenotype is conferred in the fission yeast Schizosaccharomyces pombe by expression of 
the pro-apoptotic protein Bax and Bak (Jurgensmeier el al. , 1997). Analysis of the dying 
S. pombe showed massive cytoso li c and cl1romatin condensation (Tnk el al., 1997; 
Jurgensmeier el al. , 1997). Other groups looking at cell death induced by Bax expression in 
S. pombe and S. cerevisiae observed all the major hallmarks of apo ptosis, including 
chromatin fragmentation and dissolution of the nuclear envelope (Ink et al., 1997; Madeo et 
al., 1997). Potenti al homologues of apoptotic proteins such as the caspases were sought, 
but these have not been identified even though the complete genome of S. cerevisiae is now 
known. In mammalian cell s caspases are required to carry out the execution of the cell, so 
what proteins are activated by Bax expression to cause the changes observed in the yeast? 
Both ATP and an intact F0F1-ATPase proton pump are required for Bax to mediate yeast 
cell death (Matsuyama et al., 1998; Priault et al., 1999). The release of cyt. c from 
mitochondria was observed in yeast expressing Bax. This release was independent of Vdac, 
which is thought to be involved in marnmalian cyt. c release (Figure 1-6) (Manon et al., 
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1997; Priault et al., 1999). Co-expression of Bcl-2 in Bax-expressing yeast reduced their 
mortality rate, although Bcl-2 could not protect the cell from a mutant form of Bax that 
lacks the membrane anchor (Clow et al. , 1998; Greenhalf et al., 1996; Manon et al., 1997). 
In addition, expression of Bcl-Xs or Bad together with Bcl-2 suppressed Bax-induced cell 
death in yeast (Tao et al., 1998). These data are in apparent contrast to the mammalian 
model where that Bcl-Xs and Bad bind Bcl-2, displacing sequestered Bax, which then 
causes cell death (Figure 1-5). 
Overexpression of other apoptotic proteins, such as Ced-4, also causes cell death in yeast. 
Interestingly , a mutation that disrupts Ced-4 oligomerisation abrogates its lethality in yeast 
(Tao et al., 1999). If Ced-4 can cause apoptosis in yeast without caspases then it may be 
activating some kind of distinct, evolutionarily old cell death pathway. Indeed functional 
screening in yeast strain (QX95001 ), identified a mammalian apoptosis suppresser Bax 
Inhibitor-I (BI-1) , which does not directly interact with Bax, but apparently acts through 
another, unknown, yeast protein to prevent Bax-induced cell death (Xu and Reed , 1998). 
While no homologous of the major proteins involved in apoptosis, i.e. Apaf-1 or caspases, 
have been identified in yeast, homologues of lap proteins have been identified in both S. 
pombe and S. cerevisiae (Uren et al. , 1998). These proteins appear to play a role in cell 
division but as there are no caspases in yeast, any inhibitory role in the prevention of 
caspase activation , can not be tested in yeast (Fraser et al. , 1999; Uren et al., 1999). 
Other native yeast proteins have been identified as potentially apoptotic. For instance S. 
Pombe Rad9, a cell cycle checkpoint protein has a human homologue, which encodes a 
pro-apoptotic protein containing a BH3 domain (al-Khodairy et al., 1994; Komatsu et al., 
2000). Overexpression of human Rad9 induces apoptosis in mammalian cells, which can be 
blocked by Bcl-2 (Komatsu et al. , 2000). The S. cerevisiae tsCdc48ssGsG mutant shows 
features of apoptosis, such as fragmented DNA, and condensed, fragmented chromatin, 
when cultured at non-permissive temperatures (Madeo et al., 1997). Cdc48 is a cell 
division cycle gene that plays an important role in homotypic fusion of the endoplasmic 
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reticulum (Latterich et al., 1995). A null mutation in cdc48 results in cell cycle arrest, 
creating a large budded cell with the nucleus located in the neck between the mother and 
daughter cell (Frohlich et al., 1991; Moir et al., 1982). However, it is unclear if this protein 
has a role in apoptosis in multicellular organisms. 
These findings suggest that some of the apoptotic machinery is present in lower 
eukaryotes. Whatever this machinery is, it does not appear to involve homologues of the 
mammalian apoptotic proteins, such as the Bcl-2 family and caspases. Is there another set 
of proteins that are involved in an ancient form of apoptosis that we haven ' t ye t 
uncovered? 
1.8.3 ROS - an evolutionarily ancient method of cell death? 
ROS are generated during apoptosis in multicellular organisms and in certain circumstances 
ROS are generated in yeast. Indeed, Madeo et al. (1997) found that depletion of 
glutathione or the addition of low doses of H20 2 could induce apoptotic features , such as 
DNA fragmentation , in S. cerevisiae. These oxygen stress-induced features can be averted 
by hypoxia or the depletion of oxygen radicals (Madeo et al., 1997). Lipid hydroperoxide 
has also been shown to generate ROS in S. cerevisiae, however the subsequent death of the 
yeast did not involve DNA fragmentation (Aoshima et al. , 1999). 
1.9 IN VITRO MODELS OF APOPTOSIS 
Apoptosis is an asynchronous event in neuronal cells (Messam and Pittman, 1998; Mills et 
al., 1997). A cell induced to undergo apoptosis will take anywhere between 12 and 48 
hours to decide to die. Then, having reached a decision, the cell can take as little as 15 
minutes or as long as 2 hours to be completely engulfed by surrounding cells. Cells that 
have had their cell cycle synchronised still die at different times. This cell death 
asynchrony makes biochemical analyses difficult. One method to overcome this problem is 
the development of cell free systems, which are briefly described below. These systems 
have the advantage that reagents can be added that would not normally cross the cell 
membrane barrier. 
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One in vitro system employs apoptotic Xenopus laevis (African clawed frog) egg cytosolic 
extracts. Extracts, made from oocytes harvested from frogs treated with hormones to 
trigger egg production, incubated with nuclei isolated from either sperm or rat liver, can 
induce apoptosis (Newmeyer et al., 1994 ). Removal of the mitochondrial fraction of the 
extracts inhibited apoptosis induction, as did the addition of the Bcl-2 protein. A second in 
vitro system is based on extracts made from chicken DU249 cells that become apoptotic 
after S phase/M phase synchronisation (Lazebnik et al., 1993). The cytosolic extracts 
from these cells induced apoptosis in purified HeLa nuclei. A third in vitro system uses 
cytosolic extracts from control or apoptotic HL-60 cells, which are incubated with isolated 
nuclei (Salary et al., 1993). Initial elucidation of many of the factors involved in apoptosis 
came from using these in vitro models of apoptosis. In fact, the requirement of both cyt. c 
and ATP for apoptosis was elucidated through isolation of components of HeLa cell 
cytosol that induce apoptosis (Liu et al. , 1996). 
Apoptosis has been implicated in neurodegenerative disorders, and a cell-free system has 
also been designed to look at apoptosis in a neuron like system. The system devised by 
Ellerby et al., ( 1997) can look at the induction of apoptosis at three levels: the 
pre-mitochondrial , mitochondrial and post-mitochondrial release of cyt. c using tamoxifen, 
mastoparan and cyt. c, respectively. Interestingly, Bcl-2 was only able to inhibit 
apoptosis at the pre-mitochondrial and mitochondrial levels of this system (Ellerby et al. , 
1997). 
In vitro models of apoptosis are a powerful way of manipulating cell components to 
determine the role of particular proteins in apoptosis and the identification of new factors. 
In this Masterate project, in vitro reconstitution experiments were used to dissect the 
components involved in apoptosis. Francois and Grimes (1999) developed an in vitro 
model of apoptosis using two neuron-like cell lines, PC 12 cells ( established from a rat 
adrenal pheochromocytoma) and SY5Y cells (thrice subcloned, nearly diploid, human 
neuroblastoma cell line). Incubation of nuclear and cytosolic fractions of PC12 and SY5Y 
cells, respectively, with rat cyt. c induces apoptosis (Francois and Grimes, 1999). Various 
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components of this in vitro system were used in this project to develop new in vitro 
systems in which to study apoptosis. 
1.10 THESIS OBJECTIVES 
The main objective of thi s thesis was to develop in vitro systems in which we might be 
able to identi fy novel components of apoptosis using a combination of yeast and 
man1malian cell fractions. The lack of obvious homologues to man1malian apoptotic 
proteins makes yeast an ideal naive system in which to explore the role of mammalian 
apoptotic proteins, and potential interaction with nove l yeast proteins. 
An extension of thi s work was the development of another in vitro system to exan1ine the 
role of mitochondria in cell-free apoptosis. In this system, mitochondria, that have been 
treated wi th an agent that was repo11ed to release cyt. c , were added to the cell-free system 
of Francois and Grimes (1999) and apoptotic events were analysed. 
The fo llowing questions were addressed: 
• Can apoptosis be induced in yeast nuclei with apoptot ic mammalian cytosol? 
• Can yeast cell components cause apoptosis in PC 12 nucle i? 
• Is yeast cyt. c sufficient to acti vate apoptos is in mammalian or yeast cytoso l? 
• In a cell-free ystem, can apoptosis be induced by the addi tion of isolated mitochondria 
induced to release cyt. c? 
• Can purified mitochondria from healthy cells prevent apoptosis in. vitro? 
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